Rubius Therapeutics competitorsClear all

Rubius Therapeutics's top competitors include ImCheck Therapeutics, Synartro, InProTher and RogCon.
Rubius Therapeutics
Rubius Therapeutics
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
ImCheck Therapeutics
ImCheck Therapeutics
ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .
Synartro
Synartro
Synartro is a research and development company that focuses on treatments for osteoarthritis (OA).
InProTher
InProTher
InProTher is an immunotherapy company developing immunotherapies against cancer.
RogCon
RogCon
RogCon Biosciences is a biotechnology company discovering and developing therapeutics for children suffering from SCN2A mutations that cause epilepsy, autism,and other neurological disorders.
Founding Date
Founding Date
2013
Founding Date
2015
Founding Date
2011
Founding Date
2018
Founding Date
2015
Type
Type
Public
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Smithfield, US
Locations
Marseille, FR HQ
Locations
HQ
Locations
København, DK HQ
Locations
HQ
Employees
Employees
17423% increase
Employees
393% decrease
Employees
5
Employees
15
Employees
4
Twitter followers
Twitter followers
1.2 k
Twitter followers
444
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
26
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
4.2
Average likes per tweet (last 30 days)
3.2
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
92.31%
Percentage of tweets with engagement (last 30 days)
91.67%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A

Funding

Total funding raised
Total funding raised
$ 245m
Total funding raised
$ 76.1m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

ImCheck Therapeutics
HQ
Marseille, FR
Employees
39↓ 3% decrease

ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .

View company
Synartro
HQ
Employees
5

Synartro is a research and development company that focuses on treatments for osteoarthritis (OA).

View company
InProTher
HQ
København, DK
Employees
15

InProTher is an immunotherapy company developing immunotherapies against cancer.

View company
RogCon
HQ
Employees
4

RogCon Biosciences is a biotechnology company discovering and developing therapeutics for children suffering from SCN2A mutations that cause epilepsy, autism,and other neurological disorders.

View company